Related Experiment Video
Updated: Sep 6, 2025
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.2K
[Smoking-related interstitial lung diseases]
Sebastian Röhrich1, Benedikt H Heidinger2, Florian Prayer2
1Universitätsklinik für Radiologie und Nuklearmedizin, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Wien, Österreich. sebastian.roehrich@meduniwien.ac.at.
Radiologie (Heidelberg, Germany)
|June 23, 2022
Summary
Diagnosing smoking-related interstitial lung diseases requires a structured approach, with computed tomography being key. Early smoking cessation and steroids are vital for inflammatory types, while antifibrotics may help fibrotic forms.
Area of Science:
- Pulmonology
- Radiology
- Pathology
Background:
- Smoking-related interstitial lung diseases (SR-ILDs) are a diverse group of lung conditions.
- Accurate diagnosis of SR-ILDs is crucial for effective treatment and patient prognosis.
- A systematic approach is needed to navigate the diagnostic complexities of these diseases.
Purpose of the Study:
- To outline the most common smoking-related interstitial lung diseases.
- To present a structured diagnostic workflow for identifying SR-ILDs.
- To emphasize the role of imaging and multidisciplinary collaboration.
Main Methods:
- Review of common smoking-related interstitial lung diseases.
- Description of a structured diagnostic workflow.
- Highlighting the utility of computed tomography (CT) in diagnosis.
Main Results:
- Computed tomography (CT) plays a pivotal role in the diagnostic pathway for SR-ILDs.
- A standardized CT protocol and structured assessment enhance diagnostic accuracy.
- CT may decrease the need for invasive lung biopsies.
Conclusions:
- Smoking cessation and corticosteroid therapy are primary treatments for inflammatory SR-ILDs like respiratory bronchiolitis interstitial lung disease (RB-ILD) and desquamative interstitial pneumonia (DIP).
- Antifibrotic medications (nintedanib, pirfenidone) are options for fibrotic changes, such as in idiopathic pulmonary fibrosis (IPF).
- Interdisciplinary discussion is recommended for managing patients with suspected SR-ILDs.
Related Concept Videos
01:17Other Pulmonary Disorders
905
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
905
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.0K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:30Pneumonia I: Introduction
325
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
325
01:20COPD: Pathogenesis and Clinical Features
501
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
501